指南与共识类风湿关节炎脊柱关节炎系统性红斑狼疮

OMERACT共享决策干预核心域集在风湿病试验中的背书:多步骤共识构建方法结果

Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.
指南 / 共识 · Semin Arthritis Rheum · 2021-04-06

本研究旨在就风湿病学共享决策(SDM)干预试验的OMERACT核心域集达成共识,采用OMERACT Filter 2.1方法,经五个步骤(改进草案、制作白板视频、电子调查、最终确定核心域集、虚拟研讨会投票)进行共识构建。167名来自28个国家的参与者完成调查(62%为患者/照护者),多数参与者认为各域相关(81%-95%)且清晰(82%-93%);149名参与者参加虚拟研讨会投票,核心域集获得95%背书。最终背书的核心域包括知识、选择与患者价值观一致、对选择的信心、对决策过程的满意度、对所选方案的依从性及SDM干预的潜在负面后果。

要点

  • 风湿病SDM干预试验核心域集获95%投票背书,共6个域。
  • 调查中81%-95%参与者认为域相关,82%-93%认为清晰。
  • 患者/照护者占调查参与者62%,全程参与共识构建。

核心结论

  • 国际利益相关者群体就风湿病SDM干预试验的OMERACT核心域集达成共识。

研究设计与样本

  • 遵循OMERACT Filter 2.1方法,采用共识构建方法,患者自始至终参与,共五个步骤。
  • 调查共167名来自28个国家的参与者,其中62%为患者/照护者。
  • 虚拟研讨会共149名参与者(48名患者/照护者,101名临床医生/研究者)进行投票。

主要发现

  • 多数参与者将各域评为相关(81%-95%)且清晰(82%-93%)。
  • 虚拟研讨会投票中核心域集获得95%背书。

关键数值与推荐

  • 背书的核心域包括:1-对选项及其潜在获益和危害的知识;2-所选选项与每位患者的价值观和偏好一致;3-对所选选项的信心;4-对决策过程的满意度;5-对所选选项的依从性;6-SDM干预的潜在负面后果。

临床怎么用

  • 在风湿病SDM干预试验中应采用该背书的核心域集评估干预效果。

局限性

  • 未来研究将制定核心结局测量集(Core Outcome Measurement Set)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To gain consensus on the Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials of shared decision making (SDM) interventions. METHODS: The process followed the OMERACT Filter 2.1 methodology, and used consensus-building methods, with patients involved since the inception. After developing the draft core domain set in previous research, we conducted five steps: (i) improving the draft core domain set; (ii) developing and disseminating white-board videos to promote its understanding; (iii) conducting an electronic survey to gather feedback on the draft core domain set; (iv) finalizing the core domain set and developing summaries, a plenary session video and discussion boards to promote its understanding; and (v) conducting virtual workshops with voting to endorse the core domain set. RESULTS: A total of 167 participants from 28 countries answered the survey (62% were patients/caregivers). Most participants rated domains as relevant (81%-95%) and clear (82%-93%). A total of 149 participants (n = 48 patients/caregivers, 101 clinicians/researchers) participated in virtual workshops and voted on the proposed core domain set which received endorsement by 95%. Endorsed domains are: 1- Knowledge of options, their potential benefits and harms; 2- Chosen option aligned with each patient's values and preferences; 3- Confidence in the chosen option; 4- Satisfaction with the decision-making process; 5- Adherence to the chosen option and 6- Potential negative consequences of the SDM intervention. CONCLUSION: We achieved consensus among an international group of stakeholders on the OMERACT core domain set for rheumatology trials of SDM interventions. Future research will develop the Core Outcome Measurement Set. CLINICAL SIGNIFICANCE: Prior to this study, there had been no consensus on the OMERACT core domain set for SDM interventions. The current study shows that the OMERACT core domain set achieved a high level of endorsement by key stakeholders, including patients/caregivers, clinicians and researchers.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Toupin-April K, Décary S, de Wit M, et al. Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach. Semin Arthritis Rheum. 2021. PMID: 33892937. doi:10.1016/j.semarthrit.2021.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。